Your browser doesn't support javascript.
loading
Monitoring immune function after rapid corticosteroid reduction in kidney transplant recipients / 中华医学杂志(英文版)
Chinese Medical Journal ; (24): 679-682, 2011.
Article in English | WPRIM | ID: wpr-321439
ABSTRACT
<p><b>BACKGROUND</b>Long-term use of steroid with large dosage might cause many adverse effects in kidney transplant patients; reducing steroid dosage to a low level for maintenance is helpful in avoiding the side-effects, but meanwhile, acute rejection may rise to be a main concern. The present research monitored the immune function changes and the incidence of acute rejection and infection after rapid steroid reduction to investigate the safety of this strategy.</p><p><b>METHODS</b>A prospective trial was conducted, using tacrolimus and mycophenolate mofetil as the basic immunosuppressive regimen, in addition to antibody induction with basiliximab. Corticosteroid dosage was rapidly reduced to 10 mg/d seven days post-transplantation in the experimental group, and the standard corticosteroid therapy was employed in the control group. Patient immunity was monitored by the Immune Cell Function Assay pre- and two weeks post-transplantation. The incidence of acute rejection and infection were compared between the experimental and control group.</p><p><b>RESULTS</b>Comparison of intracellular adenosine triphosphate (iATP) values detected two weeks post-transplantation for the control group ((324 ± 45) ng/ml) and the experimental group ((345 ± 91) ng/ml) did not reveal a significant difference (P > 0.05). The incidence of acute rejection was analogous between groups (P > 0.05), while an increased incidence of infection was observed in the control group (53% (n = 16)) versus the experimental group (22% (n = 6), P < 0.05). Overall, recipients in the control group had longer and more recurrent infections than those in the experimental group (P < 0.05). Patients in the control group had a lower immune response ((235 ± 35) ng/ml) than those in the experimental group ((286 ± 16) ng/ml) when infection occurred (P < 0.05).</p><p><b>CONCLUSION</b>Rapid reduction of steroid early after kidney transplantation does not lead to a significant rise in patient immunity. It is a safe and effective therapy for kidney transplant patients.</p>
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Recombinant Fusion Proteins / Prospective Studies / Kidney Transplantation / Adrenal Cortex Hormones / Therapeutic Uses / Allergy and Immunology / Immunosuppressive Agents / Metabolism / Antibodies, Monoclonal Type of study: Observational study Limits: Adolescent / Adult / Female / Humans / Male Language: English Journal: Chinese Medical Journal Year: 2011 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Recombinant Fusion Proteins / Prospective Studies / Kidney Transplantation / Adrenal Cortex Hormones / Therapeutic Uses / Allergy and Immunology / Immunosuppressive Agents / Metabolism / Antibodies, Monoclonal Type of study: Observational study Limits: Adolescent / Adult / Female / Humans / Male Language: English Journal: Chinese Medical Journal Year: 2011 Type: Article